Neuroscience Antibodies and Assays Market by Product, End-user, and Geography - Forecast and Analysis 2023-2027
- Published: Nov 2022
- Pages: 164
- SKU: IRTNTR40305
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global neuroscience antibodies and assays market size is estimated to grow by USD 1,837.68 million at a CAGR of 9.44%. With the incidences of neurological disorders increasing, both patients and doctors are looking for convenient and effective ways to cure the therapy. Healthcare systems and governments are also taking initiatives to improve access to healthcare for patients with neurological disorders. With such support, market players are also coming up with antibody manufacturing techniques such as recombinant-based engineering. The global neuroscience antibodies and assays market is competitive, owing to the presence of several regional and international vendors such as Abcam plc, Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Merck and Co. Inc., Rockland Immunochemicals Inc. Vendors compete on product portfolios, market expansion, investments in market growth initiatives, and distribution networks.
This report extensively covers market segmentation by product (consumables and instruments), end-user (pharmaceutical and biopharmaceutical companies, academic and research institutes, and hospital and diagnostic centers), and geography (North America, Europe, Asia, and the Rest of World (ROW). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
What will the Size of the Neuroscience Antibodies and Assays Market be During the Forecast Period?
To learn more about this report, Download Report Sample
Parent Market Analysis
Technavio categorizes the global neuroscience antibodies and assays market as a part of the Life Sciences Tools & Services & within the global Health Care industry. The parent, global life science tools and services market covers products and companies engaged in R&D of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for the R&D of pharmaceuticals and biotechnology products and laboratory diagnosis of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
Neuroscience Antibodies and Assays Market: Key Drivers, Trends, Challenges, and Customer Landscape
The increasing incidence of neurological disorders is notably driving the neuroscience antibodies and assays market growth, although factors such as the high development cost of neuroscience antibodies may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Neuroscience Antibodies and Assays Market Driver
The increasing incidence of neurological disorders is a key factor driving the global neuroscience antibodies and assay market growth. Patients with a comprehensive range of neurological disorders, including epilepsy, stroke, PD, and brain tumours, have a high risk of developing a disability. These disorders may also be fatal. These neurological disorders develop due to various factors such as bacterial and viral infections, genetic factors, and the lack of immune response.
Parkinson's Disease (PD) is one of the most common neurological diseases affecting the population. Factors such as the increasing incidence and prevalence of various neurological disorders and the growing demand for treating such disorders to save patients’ lives will contribute to the growth of the global neuroscience antibodies and assays market during the forecast period. Furthermore, treating brain haemorrhage due to stroke and brain tumours is boosting the demand for neuroscience antibodies and assays.
Key Neuroscience Antibodies and Assays Market Trend
The increasing number of clinical trials will fuel the global neuroscience antibodies and assays market growth. The globalization of clinical trials has consistently expanded over the past two decades, which has been credited to numerous factors, including organized trials, volunteers, availability of qualified local investigators, improved infrastructure facilities, and the low cost of conducting clinical trials in developing nations. The potential clinical advantages of disease-specific biomarkers include faster and more accurate disease analysis and potential reduction in sample size and the time involved in clinical trials, which will accelerate drug development.
The use of biomarkers in the clinical field of neurological disorders is to ascertain whether a medication achieves its proposed target or changes the course of the disease. Both the US FDA and the European Medicines Agency (EMA) perceive an important role for biomarkers in the medication improvement process, which has led to the formation of an ethical committee between developed and emerging countries to provide standard, effective, and consistent ethical guidance. This prevents the exploitation of participants in clinical trials with the US FDA's monitoring of low-cost and effective clinical trials in developing countries. Thus, the increase in the number of clinical trials will drive the growth of the market in focus during the forecast period.
Key Neuroscience Antibodies and Assays Market Challenge
The high development cost of neuroscience antibodies is a major challenge to the global neuroscience antibodies and assays market growth. The development cost of neuroscience antibodies is significantly high. Unlike other therapeutic antibodies, which can generate even billions of dollars in revenue, research antibodies sometimes do not even cover their development costs, which are in the range of only thousands of dollars. Development costs vary significantly, depending on the type of antibody generated.
Several vendors find it challenging to generate significant annual sales for their research antibodies. Several monoclonal antibodies do not reach the break-even point for a research application. Hence, most commercial research antibodies are still polyclonal ones, which cost significantly less in development. Due to the high development cost, several manufacturers of neuroscience antibodies forego exhaustive in-depth quality control of their research antibodies. Such products can lead to unsubstantiated conclusions, waste of research efforts, and faulty research publications that need to be retracted.
Key Neuroscience Antibodies and Assays Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Neuroscience Antibodies and Assays Market Customer Landscape
Who are the Major Neuroscience Antibodies and Assays Market Vendors?
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Abcam plc - The company offers neuroscience antibodies and assays that include an anti-Ki67 antibody, anti-vimentin antibody, anti-beta catenin antibody, and anti-BrdU antibody. Under the product/service, the company produces, distributes, and sells antibodies and protein research tools.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
- Abnova Corp.
- ADx NeuroSciences NV
- Bio Rad Laboratories Inc.
- Biosensis Pty Ltd.
- BMG LABTECH GmbH
- Cell Signaling Technology Inc.
- Chemie Brunschwig AG
- Elabscience Biotechnology Inc.
- Enzo Biochem Inc.
- F. Hoffmann La Roche Ltd.
- GenScript Biotech Corp.
- Merck and Co. Inc.
- NSJ Bioreagents
- PerkinElmer Inc.
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
What is the Fastest-Growing Segment in the Neuroscience Antibodies and Assays Market?
The market share growth by the consumables segment will be significant during the forecast period. A wide range of antibodies, assay kits, and reagents are used in neuroscience assays to discover new disease targets, provide high-throughput screening of clinical compounds, understand the mechanism of action, and develop clinically relevant biomarkers. There are two types of consumables, namely Antibodies and Assay kits and reagents.
Get a glance at the market contribution of various segments Request a PDF Sample
The consumables segment showed a gradual increase in market share from USD 1,567.65 million in 2017 and continued to grow by 2021. The demand for neuroscience antibodies, antigens, assay kits, and reagents has significantly increased due to the discovery of new potential drug targets, signalling molecules, and structural proteins in the brain. Furthermore, the growing significance of neuroscience processes and neurodegenerative diseases research and the wide availability of antibodies, assay kits, and reagents will drive the growth of the consumables segment during the forecast period.
Which are the Key Regions for the Neuroscience Antibodies and Assays Market?
For more insights on the market share of various regions Request PDF Sample now!
North America is projected to contribute 46% by 2027. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The increasing demand for the diagnosis of neurological disorders has boosted the demand for neuroscience antibodies and assays. For instance, an estimated 6.2 million Americans aged 65 years and older were living with Alzheimer's Disease and dementia in March 2021. This number could grow to 13.8 million by 2060. Thus, the high prevalence of neurological disorders, the growing ageing population, high healthcare expenditure on treating neurological diseases, and favourable reimbursement policies for neuro-diagnostic procedures are expected to drive market growth during the forecast period.
The increase in neurological disorders due to COVID-19 will propel R&D related to neurological symptoms, which will positively impact the market in focus during the forecast period. Moreover, the initiation of large-scale COVID-19 vaccination drives by the regional governments in Q4 of 2020 led to the lifting of lockdown restrictions and put the regional economy on track, along with a significant reduction in the number of COVID-19 patients. This, in turn, led to the lifting of cross-border restrictions and the resumption of healthcare facilities, which is expected to drive the growth of the regional market in focus during the forecast period.
Segment Overview
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. The market has been segmented by type, product, distribution channel, and region.
- Product Outlook (USD Million, 2017 - 2027)
- Consumables
- Instruments
- End-user Outlook (USD Million, 2017 - 2027)
- Pharmaceutical and biopharmaceutical companies
- Academic and research institutes
- Hospital and diagnostic centers
- Region Outlook (USD Million, 2017 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- ROW
- Argentina
- Australia
- Brazil
- Rest of the World
- North America
|
Neuroscience Antibodies and Assays Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
164 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 9.44% |
|
Market growth 2023-2027 |
USD 1,837.68 million |
|
Market structure |
Fragmented |
|
YoY growth (%) |
8.95 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 46% |
|
Key countries |
US, Germany, UK, France, and China |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Abcam plc, Abnova Corp., ADx NeuroSciences NV, Bio Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Merck and Co. Inc., NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens AG, and Thermo Fisher Scientific Inc. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Neuroscience Antibodies and Assays Market Report?
- CAGR of the market during the forecast period.
- Detailed information on factors that will drive the growth of the market between 2023 and 2027
- Precise estimation of the size of the neuroscience antibodies and assays market size and its contribution of the market in focus on the parent market.
- Accurate predictions about upcoming trends and changes in consumer behaviour.
- Growth of the neuroscience antibodies and assays market industry across North America, Europe, Asia, and Rest of World (ROW).
- A thorough analysis of the market’s competitive landscape and detailed information about vendors.
- Comprehensive analysis of factors that will challenge the growth of carbon dioxide market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global neuroscience antibodies and assays market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on Global neuroscience antibodies and assays market 2017 - 2021 ($ million)
- 4.2 Product Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
- 4.3 End-user Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – End-user Segment 2017 - 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
- 4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Consumables - Market size and forecast 2022-2027
- Exhibit 34: Chart on Consumables - Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Consumables - Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Consumables - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Consumables - Year-over-year growth 2022-2027 (%)
- 6.4 Instruments - Market size and forecast 2022-2027
- Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
- 6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
7 Market Segmentation by End-user
- 7.1 Market segments
- Exhibit 43: Chart on End-user - Market share 2022-2027 (%)
- Exhibit 44: Data Table on End-user - Market share 2022-2027 (%)
- 7.2 Comparison by End-user
- Exhibit 45: Chart on Comparison by End-user
- Exhibit 46: Data Table on Comparison by End-user
- 7.3 Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027
- Exhibit 47: Chart on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
- Exhibit 48: Data Table on Pharmaceutical and biopharmaceutical companies - Market size and forecast 2022-2027 ($ million)
- Exhibit 49: Chart on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
- Exhibit 50: Data Table on Pharmaceutical and biopharmaceutical companies - Year-over-year growth 2022-2027 (%)
- 7.4 Academic and research institutes - Market size and forecast 2022-2027
- Exhibit 51: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
- Exhibit 52: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
- Exhibit 54: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
- 7.5 Hospital and diagnostic centers - Market size and forecast 2022-2027
- Exhibit 55: Chart on Hospital and diagnostic centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 56: Data Table on Hospital and diagnostic centers - Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Chart on Hospital and diagnostic centers - Year-over-year growth 2022-2027 (%)
- Exhibit 58: Data Table on Hospital and diagnostic centers - Year-over-year growth 2022-2027 (%)
- 7.6 Market opportunity by End-user
- Exhibit 59: Market opportunity by End-user ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 61: Chart on Market share by geography 2022-2027 (%)
- Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 63: Chart on Geographic comparison
- Exhibit 64: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2022-2027
- Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
- Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
- 9.4 Europe - Market size and forecast 2022-2027
- Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
- Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
- 9.5 Asia - Market size and forecast 2022-2027
- Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
- Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
- Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- 9.7 US - Market size and forecast 2022-2027
- Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
- Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
- 9.8 Germany - Market size and forecast 2022-2027
- Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
- Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
- 9.9 China - Market size and forecast 2022-2027
- Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
- Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
- 9.10 UK - Market size and forecast 2022-2027
- Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
- Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
- 9.11 France - Market size and forecast 2022-2027
- Exhibit 97: Chart on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 98: Data Table on France - Market size and forecast 2022-2027 ($ million)
- Exhibit 99: Chart on France - Year-over-year growth 2022-2027 (%)
- Exhibit 100: Data Table on France - Year-over-year growth 2022-2027 (%)
- 9.12 Market opportunity by geography
- Exhibit 101: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 102: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 104: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 105: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 106: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 107: Matrix on vendor position and classification
- 12.3 Abcam plc
- Exhibit 108: Abcam plc - Overview
- Exhibit 109: Abcam plc - Product / Service
- Exhibit 110: Abcam plc - Key news
- Exhibit 111: Abcam plc - Key offerings
- 12.4 Abnova Corp.
- Exhibit 112: Abnova Corp. - Overview
- Exhibit 113: Abnova Corp. - Product / Service
- Exhibit 114: Abnova Corp. - Key offerings
- 12.5 ADx NeuroSciences NV
- Exhibit 115: ADx NeuroSciences NV - Overview
- Exhibit 116: ADx NeuroSciences NV - Product / Service
- Exhibit 117: ADx NeuroSciences NV - Key offerings
- 12.6 Bio Rad Laboratories Inc.
- Exhibit 118: Bio Rad Laboratories Inc. - Overview
- Exhibit 119: Bio Rad Laboratories Inc. - Business segments
- Exhibit 120: Bio Rad Laboratories Inc. - Key news
- Exhibit 121: Bio Rad Laboratories Inc. - Key offerings
- Exhibit 122: Bio Rad Laboratories Inc. - Segment focus
- 12.7 BMG LABTECH GmbH
- Exhibit 123: BMG LABTECH GmbH - Overview
- Exhibit 124: BMG LABTECH GmbH - Product / Service
- Exhibit 125: BMG LABTECH GmbH - Key offerings
- 12.8 Cell Signaling Technology Inc.
- Exhibit 126: Cell Signaling Technology Inc. - Overview
- Exhibit 127: Cell Signaling Technology Inc. - Product / Service
- Exhibit 128: Cell Signaling Technology Inc. - Key offerings
- 12.9 Chemie Brunschwig AG
- Exhibit 129: Chemie Brunschwig AG - Overview
- Exhibit 130: Chemie Brunschwig AG - Product / Service
- Exhibit 131: Chemie Brunschwig AG - Key offerings
- 12.10 Elabscience Biotechnology Inc.
- Exhibit 132: Elabscience Biotechnology Inc. - Overview
- Exhibit 133: Elabscience Biotechnology Inc. - Product / Service
- Exhibit 134: Elabscience Biotechnology Inc. - Key offerings
- 12.11 F. Hoffmann La Roche Ltd.
- Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
- 12.12 GenScript Biotech Corp.
- Exhibit 140: GenScript Biotech Corp. - Overview
- Exhibit 141: GenScript Biotech Corp. - Business segments
- Exhibit 142: GenScript Biotech Corp. - Key news
- Exhibit 143: GenScript Biotech Corp. - Key offerings
- Exhibit 144: GenScript Biotech Corp. - Segment focus
- 12.13 Merck and Co. Inc.
- Exhibit 145: Merck and Co. Inc. - Overview
- Exhibit 146: Merck and Co. Inc. - Business segments
- Exhibit 147: Merck and Co. Inc. - Key news
- Exhibit 148: Merck and Co. Inc. - Key offerings
- Exhibit 149: Merck and Co. Inc. - Segment focus
- 12.14 PerkinElmer Inc.
- Exhibit 150: PerkinElmer Inc. - Overview
- Exhibit 151: PerkinElmer Inc. - Business segments
- Exhibit 152: PerkinElmer Inc. - Key news
- Exhibit 153: PerkinElmer Inc. - Key offerings
- Exhibit 154: PerkinElmer Inc. - Segment focus
- 12.15 Rockland Immunochemicals Inc.
- Exhibit 155: Rockland Immunochemicals Inc. - Overview
- Exhibit 156: Rockland Immunochemicals Inc. - Product / Service
- Exhibit 157: Rockland Immunochemicals Inc. - Key offerings
- 12.16 Santa Cruz Biotechnology Inc.
- Exhibit 158: Santa Cruz Biotechnology Inc. - Overview
- Exhibit 159: Santa Cruz Biotechnology Inc. - Product / Service
- Exhibit 160: Santa Cruz Biotechnology Inc. - Key offerings
- 12.17 Thermo Fisher Scientific Inc.
- Exhibit 161: Thermo Fisher Scientific Inc. - Overview
- Exhibit 162: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 163: Thermo Fisher Scientific Inc. - Key news
- Exhibit 164: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 165: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 166: Inclusions checklist
- Exhibit 167: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 168: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 169: Research methodology
- Exhibit 170: Validation techniques employed for market sizing
- Exhibit 171: Information sources
- 13.5 List of abbreviations
- Exhibit 172: List of abbreviations
- growth due to the increasing number of tests for infectious and chronic diseases: The incidence of infectious and chronic diseases has increased over the past decade. The outbreak of the COVID-19 pandemic in 2020 has increased the demand for laboratory testing for COVID-19 across the world. An increase in demand for laboratory testing for infectious diseases, such as COVID-19 and chronic diseases, will be a driver for the life sciences tools and services industry in the future. The growth of the tools and services industry will continue to be strong in emerging markets such as China and India. Developed economies such as Japan and the EU will exhibit moderate growth rates.
- product development to decrease prices: As the pricing pressure increases, life sciences tools manufacturers will have to rethink product development processes. A value first product design philosophy can help control costs and deliver what customers value the most.
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Frequently Asked Questions?
- US
- Germany
- UK
- France
- China
- Increasing incidences of neurological disorders
- Increasing clinical trials in countries
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Did you know?
Did you know?
Did you know?
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
